Ansbert Gadicke, Director, 10% Owner at Cullinan Oncology, Inc. (CGEM), sold 107,469 shares at $29.11 ($3.1M) on 2021-09-08, disclosed to the SEC on 2021-09-08.
Open-market sale of $3.1M CGEM by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.60 | 1,760 | $52K | 1.7% |
| 2 | $29.60 | 12,731 | $377K | 12.0% |
| 3 | $29.60 | 12,731 | $377K | 12.0% |
| 4 | $29.04 | 3,465 | $101K | 3.2% |
| 5 | $29.04 | 3,465 | $101K | 3.2% |
| 6 | $29.04 | 25,067 |
| $728K |
| 23.2% |
| 7 | $29.04 | 25,067 | $728K | 23.2% |
| 8 | $29.11 | 1,499 | $44K | 1.4% |
| 9 | $29.11 | 10,842 | $316K | 10.1% |
| 10 | $29.11 | 10,842 | $316K | 10.1% |
| Total | $29.20 avg | 107,469 | $3.1M | 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $20.9M | — | Filing → |
| ITOS | SELL | 2021-10-14 | $5.2M | — | Filing → |
| ITOS | SELL | 2021-10-05 | $2.2M | — | Filing → |